Table 3 The peripheral blood inflammatory cell count results upon admission for COVID-19 patients and controls.
Blood parameter counts | Covid−19 group (n = 44) | Control group (n = 11) | P value | |
|---|---|---|---|---|
Critical (n = 22) | Moderate-Severe (n = 22) | |||
Neutrophils (1.8–6.3 × 109/L) | 7.18* (5.50,14.12) | 5.86 (2.78, 9.60) | 4.04 (3.29, 5.02) | 0.013 |
< 1.8 | 1/22 (4.5%) | 1/22 (4.5%) | 0 | – |
1.8–6.3 | 7/22 (31.8%) | 10/22 (45.5%) | 11/11(100%) | – |
> 6.3 | 14/22 (63.6%) | 11/22 (50.0%) | 0 | – |
Lymphocytes (1.1–3.2 × 109/L) | 0.30** (0.20, 0.55) | 0.65** (0.38, 1.13) | 2.49 (1.78, 2.82) | < 0.001 |
< 1.1 | 22/22 (100%) | 16/22 (72.7%) | 0 | – |
≥ 1.1 | 0 | 6 /22(27.3%) | 11/11(100%) | – |
NLR | 28.38**,# (15.12, 49.13) | 9.19** (4.30, 18.65) | 1.96 (1.55, 2.22) | < 0.001 |
Monocytes (0.1–0.6 × 109/L) | 0.30 (0.20, 0.48) | 0.40 (0.28, 0.53) | 0.40 (0.20, 0.50) | – |
< 0.6 | 17/22 (77.3%) | 17/22 (77.3%) | 11/11(100%) | – |
≥ 0.6 | 5/22 (22.7%) | 5/22 (22.7%) | 0 | – |
Eosinophils (0.02–0.52 × 109/L) | 0** | 0.01** (0, 0.03) | 0.32 (0.18, 0.48) | < 0.001 |
0 | 17/22 (77.3%) | 10/22 (45.5%) | 0 | – |
< 0.02 | 4 /22(18.2%) | 5/22(22.7%) | 0 | – |
≥ 0.02 | 1 /22(4.5%) | 7 /22(31.8%) | 11/11(100%) | - |
